24/7 Customer Support

Atrial Fibrillation Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2031

Global Atrial Fibrillation Market: By Type (Paroxysmal Afib, Persistent Afib, Chronic/Permanent Afib); By Technology (Microlife AFIB Technology, Hybrid Surgical-Catheter Ablation, Cryotherapy); By Treatment (Diagnosis, Medication); By End User (Hospitals, Care Centers, Outpatients, Ambulatory Services); By Region— Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2023–2031

  • Published On: 09-Dec-2022  |   Format: pdfpowerpointexcel  |  Report ID: AA1222338
    Delivery: 2 to 4 Hours


The global atrial fibrillation market is studied from 2018-2031.

The global atrial fibrillation market is projected to grow at a CAGR of 8.71% during the forecast period 2023-2031 and is expected to reach US$ 6,839.80 Million by 2031. 

Factors such as the increasing number of atrial fibrillation cases boost the market growth.

Hybrid surgical-catheter ablation segment holds the highest CAGR in the global atrial fibrillation market during the forecast period.

North America is growing with the highest CAGR during the forecast period. 

High cost of treatment restrains the growth of the global atrial fibrillation market.

US holds the major share in term of revenue in the North America atrial fibrillation market.

Type, technology, treatment and end user are the different segments in the global atrial fibrillation market.

Some of the key players operating in the market are Johnson & Johnson Ltd., Koninklijke Philips N.V., MicroPort Scientific Corporation, Sanofi-Aventis and Boston Scientific Corporation among others.